MedTrace Logo

Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

NCT03582332 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2018-07-11

No results posted yet for this study

Summary

2 Non-steroidal anti-inflammatory drugs (NSAIDs), indomethacin and etoricoxib were prescribed sequentially in Axial Spondyloarthritis patients according to the internationally accepted guidelines to determine serum creatinine change with NSAIDs use.

Conditions

  • Axial Spondyloarthritis

Interventions

DRUG

Indomethacin SR, 75 Mg Oral Capsule, Extended Release

Indomethacin SR, 75 Mg Oral Capsule, Extended Release orally twice daily

DRUG

Indomethacin 25 Mg Oral Capsule

Indomethacin 25 Mg Oral Capsule, 2 capsule orally twice daily

DRUG

Etoricoxib 90 mg

Etoricoxib 90 mg once daily orally

DRUG

Etoricoxib 60 mg

Etoricoxib 60 mg once daily orally

Sponsors & Collaborators

  • Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    lead OTHER

Principal Investigators

  • Khandker Mahbub-Uz-Zaman, MD · Resident

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2016-06-23
Completion
2016-06-23

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03582332 on ClinicalTrials.gov